Academia and Industry Join Forces in Sweden

AstraZeneca and the Karolinska Institutet, Sweden's leading medical institute have joined forces to create the Karolinska Institutet/AstraZeneca Integrated Cardio Metabolic Center. The center will be funded by a $100M USD five-year contract, with the entire financial contribution coming from AstraZeneca. While Karolinska and AstraZeneca have collaborated before, this joint center will bring researchers from academia and industry side by side to speed the development of therapies for cardio-metabolic diseases. It will be interesting to see how this collaboration goes and what new therapies are developed with the two groups working together so closely. I believe that this is an excellent model and hopefully more collaborations like this can develop in the future. 

Read the original article here: http://stm.sciencemag.org/content/6/217/217ed1.short